Granza Bio
Signal active
Organization
Contact Information
Overview
Granza Bio is a company that developing cancer therapies based on human body's immune system.
About
Industries
Biotechnology, Medical, Biopharma, Wellness
Founded
2023
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Granza Bio headquartered in United States, North America, operates in the Biotechnology, Medical, Biopharma, Wellness sector. The company focuses on Biotechnology and has secured $244.5M in funding across 32 round(s). With a team of 1-10 employees, Granza Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Granza Bio, raised $7.1M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
19
Lead Investors
0
Total Funding Amount
$7.6M
Details
2
Granza Bio has raised a total of $7.6M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Seed | 500.0K | ||
| 2024 | Seed | 7.1M |
Investors
Granza Bio is funded by 26 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Richard Aberman | - | FUNDING ROUND - Richard Aberman | 7.1M |
| Eli Brown | - | FUNDING ROUND - Eli Brown | 7.1M |
| Granza Bio | - | FUNDING ROUND - Granza Bio | 7.1M |
| Benjamin Bryant | - | FUNDING ROUND - Benjamin Bryant | 7.1M |
Recent Activity
There is no recent news or activity for this profile.